{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:14:29Z","timestamp":1778757269517,"version":"3.51.4"},"reference-count":13,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2026,1,17]]},"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1136\/thorax-2025-224687","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T18:20:33Z","timestamp":1771611633000},"page":"514-515","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["LAMA and ICS discontinuation in COPD: run-in to an exacerbation?"],"prefix":"10.1136","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4597-2722","authenticated-orcid":false,"given":"Bram","family":"van den Borst","sequence":"first","affiliation":[{"name":"Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5976-0974","authenticated-orcid":false,"given":"Wouter Heero","family":"van Geffen","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2026,2,20]]},"reference":[{"key":"2026051403202032000_81.6.514.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805800"},{"key":"2026051403202032000_81.6.514.2","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S2213-2600(15)00459-2","article-title":"Hyperinflation in COPD exacerbations","volume":"3","author":"van Geffen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2026051403202032000_81.6.514.3","article-title":"Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease","volume":"12","author":"van Geffen","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"2026051403202032000_81.6.514.4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02119-2019","article-title":"Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD","volume":"55","author":"Mathioudakis","year":"2020","journal-title":"Eur Respir J"},{"key":"2026051403202032000_81.6.514.5","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00351-2020","article-title":"Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline","volume":"55","author":"Chalmers","year":"2020","journal-title":"Eur Respir J"},{"key":"2026051403202032000_81.6.514.6","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2025-223282"},{"key":"2026051403202032000_81.6.514.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516385"},{"key":"2026051403202032000_81.6.514.8","first-page":"899","article-title":"Indacaterol-Glycopyrronium for COPD","volume":"375","author":"Wedzicha","year":"2016","journal-title":"N Engl J Med"},{"key":"2026051403202032000_81.6.514.9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00361-2017","article-title":"Run-in bias in randomised trials: the case of COPD medications","volume":"49","author":"Suissa","year":"2017","journal-title":"Eur Respir J"},{"key":"2026051403202032000_81.6.514.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.3.222"},{"key":"2026051403202032000_81.6.514.11","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S188752"},{"key":"2026051403202032000_81.6.514.12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081477","article-title":"SPIRIT 2025 statement: updated guideline for protocols of randomised trials","volume":"389","author":"Chan","year":"2025","journal-title":"BMJ"},{"key":"2026051403202032000_81.6.514.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081123","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"BMJ"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2025-224687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:20:58Z","timestamp":1778754058000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2025-224687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":13,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,5,14]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/thorax-2025-224687"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2025-224687","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]}}}